VTD in Older Patients Comparative With Younger

Belen Ballina,M. Fuertes,Seila Cerda,Violeta Martinez Robles,Paola Gonzalez,Filomeno Rodon,Jose Antonio Rodríguez-García,Fernando Escalante

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2017）

引用 0|浏览20

暂无评分

摘要

Assess the efficacy and safety of VTD (bortezomib plus thalidomide plus dexamethasone) as induction therapy before autologous stem-cell transplantation (ASCT) in both newly diagnosed and relapsed multiple myeloma, including patients (pt) over 65y.

查看译文

关键词

older patients comparative,older patients

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要